secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tempus AI, Inc. (TEM)
CIK:        0001717115
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001193125-26-009650
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tempus AI reports preliminary FY2025 revenue ~$1.27B (+83% YoY); TCV exceeds $1.1B
--------------------------------------------------------------------------------

- FY2025 revenue ~$1.27B (+83% YoY); diagnostics ~$955M (+111%), data/apps ~$316M (+31%).
- Q4 2025 revenue ~$367M (+83% YoY); diagnostics ~$266M (+121%), data/apps ~$100M (+25%).
- Record total contract value >$1.1B as of Dec 31, 2025; net revenue retention ~126%.
- Signed data agreements with >70 customers including AstraZeneca, Pfizer, Novartis, Merck, Eli Lilly, etc.
- Preliminary results subject to change; final earnings call in Feb 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1717115/000119312526009650/0001193125-26-009650-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1717115/000119312526009650/d38597d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-009650

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer